$LXEO
Lexeo Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$4.20
▲+0.48%+$0.020
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateLexeo Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is LXEO up today? It is at $4.20 (+0.48%), and our scanner flagged it 19 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LXEO spikes, and full due diligence on LXEO — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LXEO 19 times in the last 30 days. Create a free account to track $LXEO, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on LXEO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LXEO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystLexeo Therapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Aug 19, 2026 · 32 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Otero Jose Manuel Officer | Sold (automatic/other) | -1K | sold 0.9% | 136K | $6K at $4.96 | Aug 18, 26 |
Townsend Richard Nolan Officer | Sold (automatic/other) | -3K | sold 0.9% | 374K | $17K at $4.95 | Aug 18, 26 |
Tamayo Louis Edward Officer | Sold (automatic/other) | -4K | sold 4.2% | 93K | $20K at $4.91 | Aug 18, 26 |
Townsend Richard Nolan Officer | Sold (automatic/other) | -26K 0.03% of company | sold 6.4% | 378K | $116K at $4.48 | Jul 1, 26 |
Bhalla Narinder Pal Officer | Sold (automatic/other) | -22K 0.03% of company | sold 21% | 82K | $99K at $4.42 | Jul 1, 26 |
Otero Jose Manuel Officer | Sold (automatic/other) | -5K | sold 3.3% | 137K | $21K at $4.48 | Jul 1, 26 |
Tamayo Louis Edward Officer | Sold (automatic/other) | -5K | sold 4.6% | 97K | $21K at $4.49 | Jul 1, 26 |
Townsend Richard Nolan Officer | Acquired (grant/award) | +67K 0.08% of company | added 20% | 404K | n/a | Jun 29, 26 |
Bhalla Narinder Pal Officer | Acquired (grant/award) | +55K 0.07% of company | added 100% | 105K | n/a | Jun 29, 26 |
Otero Jose Manuel Officer | Acquired (grant/award) | +12K 0.01% of company | added 9.3% | 142K | n/a | Jun 29, 26 |
Tamayo Louis Edward Officer | Acquired (grant/award) | +12K 0.01% of company | added 13% | 102K | n/a | Jun 29, 26 |
Townsend Richard Nolan Officer | Sold (automatic/other) | -3K | sold 1.0% | 337K | $17K at $5.06 | May 18, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on LXEO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LXEO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
LXEO last traded at $4.20, up 0.48% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Lexeo Therapeutics, Inc. Common Stock (LXEO) is next expected to report earnings on Wednesday, November 4, 2026, about 45 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The LXEO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LXEO 19 times in the last 30 days.
LXEO (Lexeo Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $345M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LXEO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LXEO discussion
Sign in to ask a question or join the discussion.